- Business Wire•25 days ago
Dr. Reddy’s Laboratories Ltd. today announced that it successfully completed the previously announced acquisition of eight Abbreviated New Drug Applications in the U.S.
- The Wall Street Journal•28 days ago
Prem Reddy has built Prime Healthcare Service into one of the largest for-profit hospital chains in the U.S. But he has also attracted criticism, and now he is the central figure in a lawsuit.
- Zacks•last month
Dr. Reddy's (RDY) reported first-quarter fiscal 2017 earnings per American Depositary Share of 11 cents, down 79.6% from the year-ago quarter.
Dr. Reddy's Laboratories Ltd. (DRREDDY.NS)
NSE - NSE Delayed Price. Currency in INR
|Day's Range||3,055.00 - 3,055.00|
|52wk Range||2,750.05 - 4,386.60|
|1y Target Est||N/A|
|P/E Ratio (ttm)||34.58|
|Avg Vol (3m)||440,619|
|Dividend & Yield||N/A (N/A)|